# Cato Corp: overview CATO · NYSE · CIK 18255 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30 Pages: [Overview](/companies/cato.md) · [Financials](/companies/cato/financials.md) · [Filings](/companies/cato/filings.md) · [Insiders](/companies/cato/insiders.md) Latest reported revenue: [$165.5m](/filings/0001562762-26-000100.md) for Q2 FY2026, three months to 2026-08-01, from the 10-Q filed Aug 27, 2026 (XBRL us-gaap:Revenues, accession 0001562762-26-000100). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-11-02) | Q4 FY2024 (2025-02-01) | Q1 FY2025 (2025-05-03) | Q2 FY2025 (2025-08-02) | Q3 FY2025 (2025-11-01) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-05-02) | Q2 FY2026 (2026-08-01) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [146](/filings/0001562762-25-000278.md) | [158 d](/filings/0001562762-26-000041.md) | [170](/filings/0000018255-26-000004.md) | [177](/filings/0001562762-26-000100.md) | [155](/filings/0001562762-25-000278.md) | [152 d](/filings/0001562762-26-000041.md) | [171](/filings/0000018255-26-000004.md) | [166](/filings/0001562762-26-000100.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [(11.6%)](/filings/0001562762-25-000278.md) | [(9.4%) d](/filings/0001562762-26-000041.md) | [2.0%](/filings/0000018255-26-000004.md) | [3.1%](/filings/0001562762-26-000100.md) | [(5.3%)](/filings/0001562762-25-000278.md) | [(8.9%) d](/filings/0001562762-26-000041.md) | [5.2%](/filings/0000018255-26-000004.md) | [(0.4%)](/filings/0001562762-26-000100.md) | | Net margin | % | [(10.3%)](/filings/0001562762-25-000278.md) | [(8.9%) d](/filings/0001562762-26-000041.md) | [1.9%](/filings/0001562762-26-000100.md) | [3.9%](/filings/0001562762-26-000100.md) | [(3.3%)](/filings/0001562762-25-000278.md) | [(7.2%) d](/filings/0001562762-26-000041.md) | [5.4%](/filings/0001562762-26-000100.md) | [0.7%](/filings/0001562762-26-000100.md) | | Diluted EPS | $ per share | [(0.79)](/filings/0001562762-25-000278.md) | not reported | [0.17](/filings/0000018255-26-000004.md) | [0.35](/filings/0001562762-26-000100.md) | [(0.28)](/filings/0001562762-25-000278.md) | not reported | [0.47](/filings/0000018255-26-000004.md) | [0.06](/filings/0001562762-26-000100.md) | | Free cash flow | $m | [(23.8) d](/filings/0001562762-25-000278.md) | [(7.8) d](/filings/0001562762-26-000041.md) | [2.8](/filings/0000018255-26-000004.md) | [10.4 d](/filings/0001562762-26-000100.md) | [(12.9) d](/filings/0001562762-25-000278.md) | [(5.6) d](/filings/0001562762-26-000041.md) | [7.0](/filings/0000018255-26-000004.md) | [13.1 d](/filings/0001562762-26-000100.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2022-01-29) | FY2022 (2023-01-28) | FY2023 (2024-02-03) | FY2024 (2025-02-01) | FY2025 (2026-01-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [769](/filings/0001562762-24-000065.md) | [759](/filings/0001562762-25-000062.md) | [708](/filings/0001562762-26-000041.md) | [650](/filings/0001562762-26-000041.md) | [654](/filings/0001562762-26-000041.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | [5.1%](/filings/0001562762-24-000065.md) | [(0.5%)](/filings/0001562762-25-000062.md) | [(2.5%)](/filings/0001562762-26-000041.md) | [(4.1%)](/filings/0001562762-26-000041.md) | [(1.9%)](/filings/0001562762-26-000041.md) | | Net margin | % | [4.8%](/filings/0001562762-24-000065.md) | [0.0%](/filings/0001562762-25-000062.md) | [(3.4%)](/filings/0001562762-26-000041.md) | [(2.8%)](/filings/0001562762-26-000041.md) | [(0.9%)](/filings/0001562762-26-000041.md) | | Diluted EPS | $ per share | [1.65](/filings/0001562762-24-000065.md) | [0.00](/filings/0001562762-25-000062.md) | [(1.17)](/filings/0001562762-26-000041.md) | [(0.97)](/filings/0001562762-26-000041.md) | [(0.31)](/filings/0001562762-26-000041.md) | | Free cash flow | $m | [55.7](/filings/0001562762-24-000065.md) | [(6.1)](/filings/0001562762-25-000062.md) | [(12.1)](/filings/0001562762-26-000041.md) | [(27.6)](/filings/0001562762-26-000041.md) | [(5.2)](/filings/0001562762-26-000041.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/cato/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Aldebaran Capital, LLC](/funds/1448430.md) | 2026-06-30 | $3.8m | 1,169,986 | | Reduced −6,701 | | [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $2.5m | 778,940 | | Added +12,115 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $2.3m | 711,699 | | Added +7,531 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $1.8m | 561,950 | | Added +13,600 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.8m | 560,700 | Call | Added +239,500 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $1.5m | 468,532 | | Reduced −129,807 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.3m | 406,411 | | Added +14,940 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $955.5k | 294,905 | | Unchanged | | [Prescott Group Capital Management, L.L.C.](/funds/1166152.md) | 2026-06-30 | $728.2k | 224,767 | | Unchanged | | [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $693.0k | 213,900 | Call | Added +159,500 | ## Recent filings [All 717 filings](/companies/cato/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-18 | 13:00 ET | [8-K](/filings/0001562762-26-000106.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001562762-26-000106 | | 2026-08-27 | 14:00 ET | [10-Q](/filings/0001562762-26-000100.md) | Quarterly report, period 2026-08-01 | 0001562762-26-000100 | | 2026-08-25 | 14:08 ET | [8-K](/filings/0001562762-26-000096.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-26-000096 | | 2026-05-28 | 11:00 ET | [10-Q](/filings/0000018255-26-000004.md) | Quarterly report, period 2026-05-02 | 0000018255-26-000004 | | 2026-05-26 | 14:00 ET | [8-K](/filings/0001562762-26-000069.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001562762-26-000069 | | 2026-04-10 | 15:55 ET | [DEF 14A](/filings/0001206774-26-000206.md) | Proxy statement, period 2026-05-21 | 0001206774-26-000206 | | 2026-03-25 | 16:42 ET | [10-K](/filings/0001562762-26-000041.md) | Annual report, period 2026-01-31 | 0001562762-26-000041 | | 2026-03-25 | 16:04 ET | [8-K/A](/filings/0001562762-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-26-000039 | | 2026-03-23 | 16:00 ET | [8-K](/filings/0001562762-26-000036.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001562762-26-000036 | | 2025-11-25 | 13:47 ET | [10-Q](/filings/0001562762-25-000278.md) | Quarterly report, period 2025-11-01 | 0001562762-25-000278 | ## Latest annual report [Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001562762-26-000041.md), filed Mar 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 18255 - Tickers: CATO - Exchange: NYSE - SIC code: 5621 Retail-Women's Clothing Stores - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:17 ET. No prices; not investment advice.